Cargando…

Serum Cytokeratin 19 Fragment, CK19-2G2, as a Newly Identified Biomarker for Lung Cancer

BACKGROUND: CK19-2G2, a new fragment of cytokeratin 19, is a potential tumor marker for diagnosing lung cancer. The preoperative level of serum CK19-2G2 has been demonstrated to be associated with tumor metastasis and survival of breast cancer patients. This study investigated the postoperative dyna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jia, Lv, Fang, Li, Jia, Wu, Zongyong, Qi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090200/ https://www.ncbi.nlm.nih.gov/pubmed/25006982 http://dx.doi.org/10.1371/journal.pone.0101979

Ejemplares similares

Cytokeratin19-2g2, a Novel Fragment of Cytokeratin19 in Serum, Indicating a More Invasive Behavior and Worse Prognosis in Breast Cancer Patients
por: Kong, Yanan, et al.
Publicado: (2013)

Cytokeratin 19 (CK19) expression by thyroid neoplasms in a Nigerian tertiary health centre
por: Idowu, Soremekun Ademola, et al.
Publicado: (2023)

Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17
por: Khilko, Natalya, et al.
Publicado: (2010)

Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer
por: Giovanella, L., et al.
Publicado: (2017)

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
por: Uenishi, T, et al.
Publicado: (2003)

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer
por: Boeck, S, et al.
Publicado: (2013)

Pathologic Correlation of Serum Carcinoembryonic Antigen and Cytokeratin 19 Fragment in Resected Nonsmall Cell Lung Cancer
por: Lee, Seokkee, et al.
Publicado: (2013)

Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia
por: Intke, Carina, et al.
Publicado: (2021)

Serum cytokeratin 19 fragment in advanced lung cancer: could we eventually have a serum tumor marker?
por: Bastawisy, Ahmed El, et al.
Publicado: (2014)

Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer
por: Xu, Youtao, et al.
Publicado: (2015)

Clinical Usefulness of CYFRA Assay in Diagnosing Lung Cancer: Measurement of Serum Cytokeratin Fragment
por: Sugama, Yasuo, et al.
Publicado: (1994)

Establishment of Reference Intervals of Cytokeratin 19 Fragment Antigen 21-1 in Korean Adults
por: Yoon, Sumi, et al.
Publicado: (2023)

A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis
por: Eguchi, Akiko, et al.
Publicado: (2022)

Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B
por: Li, Juan, et al.
Publicado: (2017)

Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer
por: Sharma, Sushil Kumar, et al.
Publicado: (2015)

Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia
por: El Sakka, Dalia, et al.
Publicado: (2016)

The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis
por: Sumer, Sua, et al.
Publicado: (2013)

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
por: Takada, M., et al.
Publicado: (1995)

Elevated Squamous Cell Carcinoma Antigen, Cytokeratin 19 Fragment, and Carcinoembryonic Antigen Levels in Diabetic Nephropathy
por: Chen, Jianzhong, et al.
Publicado: (2017)

Evaluation of Cytokeratin-7 and Cytokeratin-19 Expression Relationship with Gleason Score in Prostatic Adenocarcinoma
por: Soltanipur, Masood, et al.
Publicado: (2023)

Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer
por: Nakata, B, et al.
Publicado: (2004)

Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer
por: PANG, LI, et al.
Publicado: (2013)

Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity
por: Goralska, Joanna, et al.
Publicado: (2023)

Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis
por: Kawabata, Yasunari, et al.
Publicado: (2010)

Predictive Value of Serum Cytokeratin 19 Level for the Feasibility of Conserving Ovaries in Endometrial Cancer
por: Xu, Jie, et al.
Publicado: (2021)

Cytokeratins 8 and 19 in the Mouse Placental Development
por: Tamai, Yoshitaka, et al.
Publicado: (2000)

Expression of cytokeratin-7 and cytokeratin-19 on newborn mice induced rhesus rotavirus as biliary atresia model
por: Setyoboedi, Bagus, et al.
Publicado: (2022)

Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders
por: Qian, Lingling, et al.
Publicado: (2020)

Increased Cytokeratin 19 Fragment Levels Are Positively Correlated with Adenosine Deaminase Activity in Malignant Pleural Effusions from Adenocarcinomas
por: Barillo, Jorge Luiz, et al.
Publicado: (2018)

Quantitative CK19 biomarker detection in breast cancer cell lines
por: Orafa, Zahra, et al.
Publicado: (2022)

The Multiple Personalities of the Regulatory Subunit of Protein Kinase CK2: CK2 Dependent and CK2 Independent Roles Reveal a Secret Identity for CK2β
por: Bibby, Ashley C., et al.
Publicado: (2005)

Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma
por: Hu, Xiaojun, et al.
Publicado: (2023)

Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction
por: Caviglia, Gian Paolo, et al.
Publicado: (2015)

Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening
por: Li, Chunqiong, et al.
Publicado: (2020)

Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma
por: Bose, Debdas, et al.
Publicado: (2012)

A Pilot Study of CK19, CK20 and GCC mRNA in the Peripheral Blood as a Colorectal Cancer Biomarker Panel
por: Mohammadi, Pouria, et al.
Publicado: (2016)

Does Neutrophil to Lymphocyte Ratio Have a Role in Identifying Cytokeratin 19-Expressing Hepatocellular Carcinoma?
por: Lee, Chao-Wei, et al.
Publicado: (2021)

The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
por: Kurtkaya-Yapicier, Ozlem, et al.
Publicado: (2003)

The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in MCF-7 Breast Cancer Cells
por: Helland, Thomas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1uo2hc62dkqe39o5blurl138m6